Home / Funds / GSA Capital Partners LLP
GSA Capital Partners LLP
The short positions this fund discloses today, across every market.
| Issuer | Market | % of capital | Since | Filing |
|---|---|---|---|---|
| Tobii AB | Sweden | 1.20% | October 1, 2026 | |
| Valneva SE | France | 1.19% | November 4, 2026 | |
| RaySearch Laboratories AB (publ) | Sweden | 1.13% | November 5, 2026 | |
| Sivers Semiconductors AB | Sweden | 1.10% | November 19, 2026 | |
| Tessellis SPA | Italy | 1.09% | November 10, 2026 | |
| Powercell Sweden AB (publ) | Sweden | 1.00% | September 11, 2026 | |
| Hilbert Group AB (publ) | Sweden | 0.88% | October 22, 2026 | |
| Oncopeptides AB | Sweden | 0.88% | October 19, 2026 | |
| Hexagon Composites | Norway | 0.85% | November 6, 2026 | |
| Cantargia AB | Sweden | 0.70% | November 9, 2026 | |
| DBV Technologies | France | 0.70% | November 17, 2026 | |
| EuroAPI | France | 0.70% | October 19, 2026 | |
| Hansa Biopharma AB | Sweden | 0.70% | September 28, 2026 | |
| Nobia AB | Sweden | 0.70% | November 11, 2026 | |
| Smart Eye Aktiebolag (publ) | Sweden | 0.70% | October 19, 2026 | |
| OssDsign AB | Sweden | 0.69% | November 11, 2026 | |
| Trevi - Finanziaria Industriale SPA | Italy | 0.61% | August 24, 2026 | |
| Magnora | Norway | 0.60% | November 19, 2026 | |
| Tubacex, S.A. | Spain | 0.59% | November 5, 2026 | |
| Intrum AB | Sweden | 0.57% | November 19, 2026 | |
| Elliptic Laboratories ASA | Norway | 0.51% | August 26, 2026 | |
| Inventiva | France | 0.50% | October 20, 2026 | |
| MedinCell | France | 0.50% | October 14, 2026 | |
| NSI N.V. | Netherlands | 0.50% | October 6, 2026 | |
| Orrön Energy AB | Sweden | 0.50% | November 11, 2026 |
Get the moves on GSA Capital Partners LLP by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Issuer | Market | % of capital | Withdrawn on | Filing |
|---|---|---|---|---|---|
| July 30, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 1.57% | ||
| July 30, 2026 | Hexagon Composites | Norway | 1.38% | July 31, 2026 | |
| July 29, 2026 | 2020 Bulkers | Norway | 2.23% | July 30, 2026 | |
| July 29, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.87% | ||
| July 28, 2026 | 2020 Bulkers | Norway | 2.36% | July 29, 2026 | |
| July 28, 2026 | Hexagon Composites | Norway | 1.46% | July 29, 2026 | |
| July 28, 2026 | Oncopeptides AB | Sweden | 1.21% | ||
| July 27, 2026 | 2020 Bulkers | Norway | 2.43% | July 28, 2026 | |
| July 24, 2026 | 2020 Bulkers | Norway | 2.55% | July 27, 2026 | |
| July 23, 2026 | 2020 Bulkers | Norway | 2.84% | July 24, 2026 | |
| July 22, 2026 | 2020 Bulkers | Norway | 2.91% | July 23, 2026 | |
| July 22, 2026 | Oncopeptides AB | Sweden | 1.11% | ||
| July 22, 2026 | Solutions 30 SE | France | 0.60% | November 6, 2026 | AMF |
| July 21, 2026 | 2020 Bulkers | Norway | 3.01% | July 22, 2026 | |
| July 21, 2026 | Valneva SE | France | 1.21% | AMF | |
| July 17, 2026 | 2020 Bulkers | Norway | 3.14% | July 20, 2026 | |
| July 17, 2026 | Tobii AB | Sweden | 1.31% | ||
| July 16, 2026 | Oncopeptides AB | Sweden | 1.03% | ||
| July 16, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.79% | ||
| July 15, 2026 | 2020 Bulkers | Norway | 3.29% | July 16, 2026 | |
| July 14, 2026 | 2020 Bulkers | Norway | 3.37% | July 15, 2026 | |
| July 13, 2026 | 2020 Bulkers | Norway | 3.49% | July 14, 2026 | |
| July 13, 2026 | Teixeira Duarte, SA | Portugal | 0.50% | ||
| July 10, 2026 | 2020 Bulkers | Norway | 3.59% | July 13, 2026 | |
| July 10, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 1.42% | ||
| July 10, 2026 | Oncopeptides AB | Sweden | 0.92% | ||
| July 10, 2026 | Tubacex, S.A. | Spain | 0.50% | ||
| July 9, 2026 | Powercell Sweden AB (publ) | Sweden | 0.91% | ||
| July 7, 2026 | 2020 Bulkers | Norway | 3.65% | July 9, 2026 | |
| July 7, 2026 | Hexagon Composites | Norway | 1.58% | July 10, 2026 | |
| July 7, 2026 | Valneva SE | France | 1.10% | AMF | |
| July 7, 2026 | Hansa Biopharma AB | Sweden | 0.59% | ||
| July 3, 2026 | Oncopeptides AB | Sweden | 0.81% | ||
| July 2, 2026 | 2020 Bulkers | Norway | 3.70% | July 7, 2026 | |
| July 2, 2026 | Hexagon Composites | Norway | 1.63% | July 6, 2026 | |
| July 1, 2026 | Salmon Evolution ASA | Norway | 0.50% | July 17, 2026 | |
| June 30, 2026 | 2020 Bulkers | Norway | 3.68% | July 1, 2026 | |
| June 29, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 1.30% | ||
| June 26, 2026 | 2020 Bulkers | Norway | 3.50% | June 29, 2026 | |
| June 26, 2026 | Oncopeptides AB | Sweden | 0.70% | ||
| June 26, 2026 | Stillfront Group AB (publ) | Sweden | 0.58% | ||
| June 25, 2026 | 2020 Bulkers | Norway | 3.45% | June 26, 2026 | |
| June 24, 2026 | Tobii AB | Sweden | 1.20% | ||
| June 24, 2026 | Valneva SE | France | 1.00% | AMF | |
| June 24, 2026 | Powercell Sweden AB (publ) | Sweden | 0.80% | ||
| June 24, 2026 | Thor Medical ASA | Norway | 0.50% | August 28, 2026 | |
| June 24, 2026 | Biesse SPA | Italy | 0.49% | ||
| June 22, 2026 | 2020 Bulkers | Norway | 3.32% | June 23, 2026 | |
| June 22, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.80% | ||
| June 22, 2026 | Oncopeptides AB | Sweden | 0.60% |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 4,324 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats
The funds short on the same companies
- Citadel Securities (Europe) Limited 5 companies in common
- Arrowstreet Capital, Limited Partnership 4 companies in common
- Connor, Clark & Lunn Investment Management LTD. 3 companies in common
- D E Shaw Co LP 3 companies in common
- Two Sigma Investments, LP 3 companies in common
- Citadel Advisors LLC 2 companies in common
- PDT Partners, LLC 2 companies in common
- Worldquant, LLC 2 companies in common
- AQR Capital Management LLC 1 company in common
- Actus Ray Partners Limited 1 company in common
- ActusRayPartners Limited 1 company in common
- BlackRock Financial Management Inc 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, GSA Capital Partners LLP, data as at November 19, 2026, https://www.quivad.com/detenteur/gsa-capital-partners-llp?page=4